Clinical Trial Update: Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers [Phase 3]

View source ↗

Summary

Phase 3 trial comparing neoadjuvant FOLFOXIRI to immediate surgery for stage II and III colon cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• FOLFOXIRI (folinic acid (leucovorin), fluorouracil (5-FU), oxaliplatin, irinotecan)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colon Cancer Stage II, Colon Cancer Stage III | Phase 3 | Status: RECRUITING